Antiphospholipid antibodies in patients with Graves’ orbitopathy: preliminary data

[1] Bartalena L(2012)Prevention of Graves’ ophthalmopathy Best. Pract. Res. Clin. Endocrinol. Met. 26 371-379

[2] Bartalena L(2009)Graves’ ophthalmopathy N. Engl. J. Med. 360 994-1001

[3] Tanda ML(2012)Immunopathogenesis of Graves’ ophthalmopathy: The role of the TSH receptor Best. Pract. Res. Clin. Endocrinol. Met. 26 281-289

[4] Seethalakshmi I(2012)Evaluating Graves’ orbitopathy Best. Pract. Res. Clin. Endocrinol. Met. 26 229-248

[5] Bahn R(2014)14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends Autoimmun. Rev. 13 917-930

[6] Dolman PJ(2016)Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data Clin. Rheumatol. 35 2477-2483

[7] Bertolaccini ML(2017)Antibodies against complement components: relevance for the antiphospholipid syndrome-biomarkers of the disease and biopharmaceuticals Curr. Rheumatol. Rep. 19 1-9

[8] Ammengual O(2004)Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases Ann. Rheum. Dis. 63 1159-61

[9] Andreolii L(2017)Thyroid autoimmunity and antiphospholipid syndrome: not such a trivial association Front. Endocrinol. 8 175-389

[10] Bećarević M(2006)Clinical assessment of patients with Graves’ orbitopathy: the European group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers Eur. J. Endocrinol. 155 387-26

[1] Bartalena L(2012)Prevention of Graves’ ophthalmopathy Best. Pract. Res. Clin. Endocrinol. Met. 26 371-379

[2] Bartalena L(2009)Graves’ ophthalmopathy N. Engl. J. Med. 360 994-1001

[3] Tanda ML(2012)Immunopathogenesis of Graves’ ophthalmopathy: The role of the TSH receptor Best. Pract. Res. Clin. Endocrinol. Met. 26 281-289

[4] Seethalakshmi I(2012)Evaluating Graves’ orbitopathy Best. Pract. Res. Clin. Endocrinol. Met. 26 229-248

[5] Bahn R(2014)14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends Autoimmun. Rev. 13 917-930

[6] Dolman PJ(2016)Proinflammatory proteins in female and male patients with primary antiphospholipid syndrome: preliminary data Clin. Rheumatol. 35 2477-2483

[7] Bertolaccini ML(2017)Antibodies against complement components: relevance for the antiphospholipid syndrome-biomarkers of the disease and biopharmaceuticals Curr. Rheumatol. Rep. 19 1-9

[8] Ammengual O(2004)Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases Ann. Rheum. Dis. 63 1159-61

[9] Andreolii L(2017)Thyroid autoimmunity and antiphospholipid syndrome: not such a trivial association Front. Endocrinol. 8 175-389

[10] Bećarević M(2006)Clinical assessment of patients with Graves’ orbitopathy: the European group on Graves’ Orbitopathy recommendations to generalists, specialists and clinical researchers Eur. J. Endocrinol. 155 387-26